Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Novel Algorithm for Real-Time Bedside Assessment of Insulin Resistance in Critically Ill Patients Based on Continuous Glucose Monitoring Data: A Multicenter, Observational, Prospective Study

NCT07385391 is registered in ClinicalTrials.gov with Chinese Medical Association as lead sponsor.

NCT NCT07385391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07385391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Novel Algorithm for Real-Time Bedside Assessment of Insulin Resistance in Critically Ill Patients Based on Continuous Glucose Monitoring Data: A Multicenter, Observational, Prospective Study
Lead sponsor
Chinese Medical Association
Phase
Observational
Overall status
Completed
Start date
July 13, 2023
Completion date
October 1, 2025
Enrollment
179 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, insulin resistance, metabolism disorders